meta
|
Preg
- medecines during pregnancy KB
Search
Albendazole
Overall results
Study description
Excluded studies
Table
Graphic
auto
during pregnancy (anytime or not specified)
1st trimester
2nd trimester
3rd trimester
2nd and/or 3rd trimester
throughout pregnancy
early pregnancy
days before delivery
late pregnancy
preconception-only
periconceptional
preconceptional for kinetic reason
at least 1st trimester
3 months (or more) before pregnancy or during pregnancy
1st and 2nd trimester
3 months or more before pregnancy or1st trimester
Whatever the period exposition
individual studies
Outcome
TE
95% CI
n cases
n exposed
k
Pub. bias
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)
Gyapong, 2003 Choi, 2017
2
1.71
[
0.50
; 5.82]
13
104
not evaluable
Congenital heart defects
0
-
-
-
-
-
Nervous system anomalies
0
-
-
-
-
-
Limb defects
0
-
-
-
-
-
Major congenital malformations
Choi, 2017
1
2.20
[
0.49
; 9.89]
7
64
not evaluable
Minor congenital malformations
Choi, 2017
1
1.10
[
0.39
; 3.11]
18
64
not evaluable
Neonatal disorders
Jaundice / Icterus
Choi, 2017
1
1.10
[
0.39
; 3.11]
18
64
not evaluable
Neonatal medical care
0
-
-
-
-
-
Long term consequences
Infant asthma
Mpairwe (Controls unexposed, sick), 2011
1
1.58
[
1.13
; 2.21]
-
583
not evaluable
Intrauterine deaths
Early intrauterine death (< 22 weeks)
Gyapong, 2003 Choi, 2017
2
1.41
[
0.55
; 3.60]
22
118
not evaluable
Elective/induced termination of pregnancy
Choi, 2017
1
2.82
[
0.39
; 20.44]
4
70
not evaluable
Intrauterine deaths (as a whole or unspecified)
Celik, 2018
1
11.00
[
0.16
; 780.07]
3
1
not evaluable
0.0
100.0
1.0
